These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 27503751)
41. Definition of contrast enhancement phases of the liver using a perfluoro-based microbubble agent, perflubutane microbubbles. Shunichi S; Hiroko I; Fuminori M; Waki H Ultrasound Med Biol; 2009 Nov; 35(11):1819-27. PubMed ID: 19713032 [TBL] [Abstract][Full Text] [Related]
42. Diagnostic Accuracy of Hepatic Vein Arrival Time Performed with Contrast-Enhanced Ultrasonography for Cirrhosis: A Systematic Review and Meta-Analysis. Kim G; Shim KY; Baik SK Gut Liver; 2017 Jan; 11(1):93-101. PubMed ID: 27538445 [TBL] [Abstract][Full Text] [Related]
43. Double-contrast-enhanced sonography for diagnosis of rectal lesions with pathologic correlation. Lu M; Yan B; Song J; Ping W; Yue LX; Song B J Ultrasound Med; 2014 Apr; 33(4):575-83. PubMed ID: 24658937 [TBL] [Abstract][Full Text] [Related]
44. Hepatic vein transit time of second-generation ultrasound contrast agent: new tool in the assessment of portal hypertension. Luisa S; Vitale G; Sorbo AR; Maurizio P; Lodovico RG J Ultrasound; 2017 Mar; 20(1):43-52. PubMed ID: 28298943 [TBL] [Abstract][Full Text] [Related]
45. Intrahepatic circulatory time analysis of an ultrasound contrast agent in liver cirrhosis. Hirota M; Kaneko T; Sugimoto H; Kure S; Inoue S; Takeda S; Nakao A Liver Int; 2005 Apr; 25(2):337-42. PubMed ID: 15780059 [TBL] [Abstract][Full Text] [Related]
46. Non-invasive evaluation of liver cirrhosis using ultrasound. Goyal N; Jain N; Rachapalli V; Cochlin DL; Robinson M Clin Radiol; 2009 Nov; 64(11):1056-66. PubMed ID: 19822238 [TBL] [Abstract][Full Text] [Related]
47. New noninvasive ultrasound techniques: can they predict liver cirrhosis? Yu H; Wilson SR Ultrasound Q; 2012 Mar; 28(1):5-11. PubMed ID: 22357223 [TBL] [Abstract][Full Text] [Related]
48. Contrast-enhanced ultrasonography using Sonazoid to evaluate changes in hepatic hemodynamics in acute liver injury. Miyazaki M; Kato M; Tanaka M; Tanaka K; Takao S; Kohjima M; Ito T; Enjoji M; Nakamuta M; Kotoh K; Takayanagi R J Gastroenterol Hepatol; 2011 Dec; 26(12):1749-56. PubMed ID: 21615794 [TBL] [Abstract][Full Text] [Related]
49. Hepatic vein transit time of SonoVue: a comparative study with Levovist. Lim AK; Patel N; Eckersley RJ; Goldin RD; Thomas HC; Cosgrove DO; Taylor-Robinson SD; Blomley MJ Radiology; 2006 Jul; 240(1):130-5. PubMed ID: 16720867 [TBL] [Abstract][Full Text] [Related]
50. Saline-enhanced ultrasonography: prediction of X-ray appearance of hepatic venography in patients with cirrhosis. Maruyama H; Kiyono S; Kamesaki H; Kondo T; Sekimoto T; Yokosuka O Scand J Gastroenterol; 2014 May; 49(5):625-31. PubMed ID: 24646346 [TBL] [Abstract][Full Text] [Related]
51. Washout Ratio in the Hepatic Vein Measured by Contrast-Enhanced Ultrasonography to Distinguish Between Inflammatory and Noninflammatory Hepatic Disorders in Dogs. Morishita K; Hiramoto A; Michishita A; Takagi S; Osuga T; Lim SY; Nakamura K; Sasaki N; Ohta H; Takiguchi M J Vet Intern Med; 2017 May; 31(3):770-777. PubMed ID: 28382699 [TBL] [Abstract][Full Text] [Related]
52. Dynamic Contrast-Enhanced Sonography and Dynamic Contrast-Enhanced Magnetic Resonance Imaging for Preoperative Diagnosis of Infected Nonunions. Fischer C; Preuss EM; Tanner M; Bruckner T; Krix M; Amarteifio E; Miska M; Moghaddam-Alvandi A; Schmidmaier G; Weber MA J Ultrasound Med; 2016 May; 35(5):933-42. PubMed ID: 27036169 [TBL] [Abstract][Full Text] [Related]
53. Hepatic vein morphology: a new sonographic diagnostic parameter in the investigation of cirrhosis? Vessal S; Naidoo S; Hodson J; Stella DL; Gibson RN J Ultrasound Med; 2009 Sep; 28(9):1219-27. PubMed ID: 19710220 [TBL] [Abstract][Full Text] [Related]
54. [A comparative study of the hepatic transit time (HTT) of different ultrasound contrast agents in patients with liver metastases and healthy controls]. Haendl T; Strobel D; Neureiter D; Esser K; Frieser M; Hahn EG; Bernatik T Ultraschall Med; 2010 Dec; 31(6):582-8. PubMed ID: 20183780 [TBL] [Abstract][Full Text] [Related]
55. Changing waveform during respiration on hepatic vein Doppler sonography of severe portal hypertension: comparison with the damping index. Kim SY; Jeong WK; Kim Y; Heo JN; Kim MY; Kim TY; Sohn JH J Ultrasound Med; 2011 Apr; 30(4):455-62. PubMed ID: 21460144 [TBL] [Abstract][Full Text] [Related]
56. Hepatic arterialization can predict the development of collateral veins in patients with HCV-related liver disease. Wakui N; Nagai H; Ogino Y; Kobayashi K; Matsui D; Mukozu T; Matsukiyo Y; Matsui T; Daido Y; Momiyama K; Shinohara M; Kudo T; Maruyama K; Sumino Y; Igarashi Y J Ultrasound; 2018 Dec; 21(4):301-308. PubMed ID: 30291594 [TBL] [Abstract][Full Text] [Related]
57. Noninvasive diagnosis of hepatic fibrosis in patients with chronic hepatitis C by splenic Doppler impedance index. Liu CH; Hsu SJ; Lin JW; Hwang JJ; Liu CJ; Yang PM; Lai MY; Chen PJ; Chen JH; Kao JH; Chen DS Clin Gastroenterol Hepatol; 2007 Oct; 5(10):1199-1206.e1. PubMed ID: 17916547 [TBL] [Abstract][Full Text] [Related]
58. Liver Surface Nodularity Quantification from Routine CT Images as a Biomarker for Detection and Evaluation of Cirrhosis. Smith AD; Branch CR; Zand K; Subramony C; Zhang H; Thaggard K; Hosch R; Bryan J; Vasanji A; Griswold M; Zhang X Radiology; 2016 Sep; 280(3):771-81. PubMed ID: 27089026 [TBL] [Abstract][Full Text] [Related]
60. Usefulness of Contrast-Enhanced Ultrasonography for Predicting Esophageal Varices in Patients with Hepatitis B Virus (HBV)-Related Cirrhosis. Li J; Feng JC; Peng XY; Wu XW; Du TT; Wang JJ; Tian SX; Lu GL Med Sci Monit; 2017 May; 23():2241-2249. PubMed ID: 28496092 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]